跳至主要内容
临床试验/NCT03858231
NCT03858231
招募中
4 期

The Effects of Combination Therapy of Opioids Versus Non-Opioids on Postoperative Pain Management After Knee Arthroscopic Surgery: A Prospective Randomized Controlled Study

Sanford Health1 个研究点 分布在 1 个国家目标入组 148 人2018年10月29日

概览

阶段
4 期
干预措施
Norco 5Mg-325Mg Tablet
疾病 / 适应症
Knee Injuries
发起方
Sanford Health
入组人数
148
试验地点
1
主要终点
Change from Baseline Pain Assessment at 2 weeks
状态
招募中
最后更新
2个月前

概览

简要总结

The purpose of this study is to look at pain management with opioids versus non-opioids after knee arthroscopy. This study will determine 1) whether the most commonly used non-narcotic medications provide pain relief comparable with the most commonly prescribed narcotic medications in patients undergoing arthroscopic knee surgery, and 2) whether patients' characteristics (gender, pre-operative knee symptoms, workers compensation status and employment status) affect pain level following surgery or medication usage.

注册库
clinicaltrials.gov
开始日期
2018年10月29日
结束日期
2028年1月1日
最后更新
2个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Subjects ≥ 18 years of age through ≤ 80 years of age
  • Subjects undergoing elective arthroscopic knee surgery, to include partial meniscectomy, chondroplasty, or loose body removal.

排除标准

  • Previously enrolled in this study (enrolled for contralateral knee in this study)
  • Knee arthroscopy patients scheduled for knee ligament reconstructions
  • Bilateral knee arthroscopy
  • History of chronic opioid use or long-term analgesic therapy
  • Documented or suspected substance abuse
  • Documented or suspected chronic pain syndrome
  • Any known allergy or adverse reaction or contraindication to the components of hydrocodone, acetaminophen, or ibuprofen
  • History or symptoms of any significant medical problem in the last year (i.e., arrhythmia, impaired cardiovascular function, gastrointestinal bleeding, liver disease, renal disease)
  • With active peptic ulcer disease (history of severe heartburn)
  • Symptoms of infection with initial enrollment

研究组 & 干预措施

Opioid

干预措施: Norco 5Mg-325Mg Tablet

Non-opioid

干预措施: Ibuprofen 600 mg

Non-opioid

干预措施: Acetaminophen 325Mg Tab

结局指标

主要结局

Change from Baseline Pain Assessment at 2 weeks

时间窗: Daily for 2 weeks post-operatively

Visual Analog Scale from 0 to 10 with 0 being no pain and 10 being worst possible, unbearable, excruciating pain

Change from Baseline Medication Use at 2 weeks

时间窗: Daily for 14 days post-operatively

Patients will be asked how many study medication capsules have they taken.

次要结局

  • Change from Baseline Patient Reported Outcome Measurement Information System (PROMIS) at 6 weeks(baseline, 2 weeks, and 6 weeks post-operatively)
  • Change from Baseline Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 weeks(baseline, 2 weeks, and 6 weeks post-operatively)

研究点 (1)

Loading locations...

相似试验